Catalog No.
FHG11910
Species reactivity
Human
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Conjugation
Unconjugated
Target
CMK, HuMIG, Monokine induced by interferon-gamma, Small-inducible cytokine B9, C-X-C motif chemokine 9, MIG, CXCL9, SCYB9, Gamma-interferon-induced monokine
Concentration
2.36 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q07325
Applications
ELISA, FCM
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA0465
The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): Emerging therapeutic opportunities., PMID:40516902
Autophagy inhibition amplifies anti-tumor immunity effect of dinutuximab beta on neuroblastoma via the VEGFR/AKT/mTOR and ROS/NF-κB pathways., PMID:40378433
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice., PMID:40360777
Plasma Levels of CXCL9 and MCP-3 are Increased in Asthma-COPD Overlap (ACO) Patients., PMID:40297845
Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study., PMID:40276503
Parabacteroides distasonis promotes CXCL9 secretion of tumor-associated macrophages and enhances CD8+T cell activity to trigger anti-tumor immunity against anti-PD-1 treatment in non-small cell lung cancer mice., PMID:40241108
Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy., PMID:40238455
Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice., PMID:40200137
CXCL9 and IL-18: potential biomarkers for efficacy evaluation in refractory hemophagocytic lymphohistiocytosis treated with RED (ruxolitinib, emapalumab and dexamethasone)., PMID:40186662
Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity., PMID:40168086
Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13., PMID:40118130
Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma., PMID:40087599
Sequential activation of conventional and plasmacytoid dendritic cells in autoimmune pancreatitis and systemic lupus erythematosus: similarities and dissimilarities., PMID:40040712
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing., PMID:40034424
Denosumab Enhances Antitumor Immunity by Suppressing SPP1 and Boosting Cytotoxic T Cells., PMID:40009710
Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis., PMID:39943917
Congestion Enriches Intra-hepatic Macrophages Through Reverse Zonation of CXCL9 in Liver Sinusoidal Endothelial Cells., PMID:39923846
GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis., PMID:39885986
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity., PMID:39869499
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity., PMID:39734394
Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy., PMID:39701282
Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma., PMID:39658648
PPAB001, a novel bispecific antibody against CD47 and CD24, enhances anti-PD-L1 efficacy in triple-negative breast cancer via reprogramming tumor-associated macrophages towards M1 phenotype., PMID:39622130
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity., PMID:39604727
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer., PMID:39578450
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study., PMID:39455338
Distinct Non-Human Leukocyte Antigen Antibody Signatures Correlate with Endothelial Crossmatch Status in Lung and Renal Transplant Recipients., PMID:39408890
Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review., PMID:39337081
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial., PMID:39283727
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit., PMID:39281667
Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans., PMID:39277910
A positive cytokine/chemokine feedback loop establishes plasmacytoid DC-driven autoimmune pancreatitis in IgG4-related disease., PMID:39264798
Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration., PMID:39260826
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study., PMID:39241964
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling., PMID:39223366
CD4, but not Cxcr6, is necessary for control of Pneumocystis murina infection., PMID:39182643
Clinical significance of serum CXCL9, CXCL10, and CXCL11 in patients with lupus nephritis., PMID:39172029
Poly I:C vaccination drives transient CXCL9 expression near B cell follicles in the lymph node through type-I and type-II interferon signaling., PMID:39168064
Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF., PMID:39078728
Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights., PMID:39031103
Pt-Te-Nanorod-Based Photothermal Chemokine Immunotherapy for All Stages of Cancer via Adaptive and Innate Immunity., PMID:39007297
L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift., PMID:38979610
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma., PMID:38963640
Vagus nerve modulates acute-on-chronic liver failure progression via CXCL9., PMID:38945689
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma., PMID:38934093
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets., PMID:38928238
Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion., PMID:38885457
Distinct inflammatory markers in primary and secondary dengue infection: can cytokines CXCL5, CXCL9, and CCL17 act as surrogate markers?, PMID:38884301
Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor-associated myocarditis., PMID:38850163
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1., PMID:38810185
For research use only. Not for human or drug use.
